ResMed | RMD - Fremdkapital





Fremdkapital Veränderung Datum
Ansell USD 751.6M 113.1M 2025-12
Artivion USD 363.42M 148.07M 2026-06
AtriCure USD 61M 0 2026-06
Baxter International USD 8.62B 6M 2026-06
Cochlear AUD 200M 6.5M 2025-12
Cooper Companies USD 1.86B 17.7M 2026-03
CSL USD 10.42B 273M 2025-12
Dexcom USD 1.3B 200K 2026-06
Edwards Lifesciences USD 598.7M 1.3M 2026-06
Fisher Paykel Healthcare NZD 113.3M 50.7M 2026-06
Globus Medical USD 398K 38K 2026-03
Haemonetics USD 1.17B 50.36M 2026-06
Idexx Laboratories USD 299.86M 11K 2026-06
Inogen USD 0 0 2022-06
Insulet USD 929.5M 0 2026-06
Integra LifeSciences USD 1.83B 2.05M 2026-06
Intuitive Surgical USD 0 0 2025-03
Medtronic USD 27.88B 255M 2025-12
Philips EUR 6.32B 575M 2026-06
Ramsay Health Care AUD 11.2B 5.74B 2025-12
ResMed USD 399.42M 4.75M 2026-06
Sigma Healthcare AUD 1.88B 1.75B 2025-12
Sonic Healthcare AUD 4.19B 333.39M 2024-12
Steris USD 1.65B 162.6M 2026-06
Teleflex USD 2.72B 206.24M 2026-06
Thermo Fisher Scientific USD 39.18B 890M 2026-06